Loading resource…

Jihoon Kim and Sang-Chol Lee
Hypertrophic cardiomyopathy (HCM) is characterized by unexplained myocardial hypertrophy, and its diagnosis traditionally relies on increased left ventricular wall thickness. However, contemporary management necessitates a comprehensive imaging strategy to accurately define disease phenotype, assess functional consequences, and guide risk stratification. This review summarizes the roles of transthoracic echocardiography, cardiac magnetic resonance, and cardiac computed tomography in evaluating cardiac morphology and function, emphasizing the need for an integrated approach to optimize diagnosis and therapeutic decision-making in HCM patients.
No account needed